KATHERINE MARTIN-BREDAHL: Open Payments
NPI 1427388776 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 22 payments from 17 companies in 2025. Trend: 2023 $1,352 · 2024 $1,735 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Lilly USA, LLC | 2 | $42 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Verity Pharmaceuticals Inc. | 1 | $33 |
| PFIZER INC. | 2 | $31 |
| ABBVIE INC. | 1 | $24 |
| Medtronic, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: LEQVIO, MOUNJARO, ZENPEP, Tlando, QULIPTA, INCEPTIV, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across MO — which companies pay providers there.
